Skip to main content
. 2008 Aug 18;29(11):2112–2119. doi: 10.1093/carcin/bgn189

Table V.

CART terminal nodes and RCC risk

Terminal nodea Cases/controlsb Case rate (%) Adjusted ORc P-value
1 23/53 30.26 Ref.
2 8/18 30.77 1.25 (0.45–3.41) 0.67
3 18/16 52.94 3.92 (1.62–9.48) 0.002
4 19/31 38.00 1.79 (0.81–3.98) 0.15
5 43/38 53.09 3.31 (1.62–6.76) 0.001
6 25/29 46.30 2.41 (1.11–5.25) 0.03
7 25/14 64.10 5.67 (2.34–13.74) <0.001
8 39/46 45.88 2.39 (1.19–4.82) 0.01
9 37/18 67.27 6.37 (2.86–14.19) <0.001
10 23/8 74.19 7.63 (2.84–20.50) <0.001
a

Refer to Figure 1 for definition of each terminal node.

b

The total number of cases and controls does not add up to 325 and 335, respectively, because only subjects without missing SNP data were included in the analysis.

c

Adjusted for age, gender, smoking status, hypertension and body mass index.